ENVB · Forms 3, 4, 5
Insider trades at Enveric Biosciences, Inc.
No open-market insider buys or sells at Enveric Biosciences, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Enveric Biosciences, Inc. (ENVB) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Enveric Biosciences, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Kevin Michael Coveney | Chief Financial Officer | Award | 133,333 | Form 4 | |||
| Joseph Edward Tucker | Chief Executive Officer | Award | 201,124 | Form 4 | |||
| Frank Pasqualone | Director | Award | 18,518 | Form 4 | |||
| Michael D Webb | Director | Award | 18,518 | Form 4 | |||
| Marcus Schabacker | Director | Award | 18,518 | Form 4 | |||
| George A. Kegler | Director | Award | 18,518 | Form 4 | |||
| Sheila DeWitt | Director | Award | 18,518 | Form 4 | |||
| Peter J. Facchini | Chief Innovation Officer | Award | 25,000 | Form 4 | |||
| Sheila DeWitt | Director | Award | 7,633 | Form 4 | |||
| George A. Kegler | Director | Award | 7,633 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.